Medical Use
Fabrazyme is an enzyme that specifically targets neutral glycosphingolipids in lysosomes. It is used to treat both adults and children aged 2 years and older who have been diagnosed with Fabry disease. Fabry disease is an inherited disease caused by the lack of an enzyme called alpha-galactosidase A in the body. This enzyme is necessary for your body. Agalsidase beta is used to help replace this enzyme.
Warning & Precautions
Patients undergoing enzyme replacement therapy may experience allergic reactions, some of which can be severe or life-threatening, such as anaphylaxis. These reactions can occur early in the treatment or after multiple sessions.
Fabrazyme should be administered by your healthcare provider in a medical setting equipped with proper monitoring and support. If a severe allergic or anaphylactic reaction happens, the infusion will be stopped immediately, and appropriate medical treatment will be given. If symptoms is observed, medical attention is recommended immediately.
Documentation Availability
Fabrazyme can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing Fabrazyme from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the Generic Name for the trade name drug Fabrazyme?
Agalsidase beta is Generic Name for the trade name drug Fabrazyme.
What is the Manufacturer Name of Fabrazyme ?
Fabrazyme is manufactured by Genzyme
What is the dosage and form of FABRAZYME available?
For injection: 5 mg or 35 mg lyophilized cake or powder in a single-dose vial for reconstitution.
What are the side effects of EVRYSDI?
Fabrazyme can cause serious side effects like
Severe Allergic Reactions Including Anaphylaxis-Approximately 1% of patients who received Fabrazyme experienced a severe allergic or anaphylactic reaction during their infusion. Some of these reactions were life-threatening, and include-Swelling of the face, mouth and throat, narrowing of breathing airways, low blood pressure, hives, difficulty swallowing, rash, trouble breathing, flushing, chest discomfort, itching and nasal congestion.
Infusion-Associated Reactions-In clinical studies, 59% of patients experienced infusion-associated reactions (IARs) during Fabrazyme administration, some of which were severe. IARs are defined as those occurring on the same day as the infusion. IARs occurred more frequently in patients who were positive for anti-Fabrazyme antibodies than those who did not have anti-Fabrazyme antibodies.
Side effects reported in 20% or more of Fabrazyme treated patients in clinical studies compared to placebo were upper respiratory tract infection, chills, fever, headache, cough, burning and/or tingling sensation, fatigue, swelling in the legs, dizziness, and rash.
Where can I get Fabrazyme at the best price in India?
To get the best Fabrazyme price in India, kindly contact Rx4u team.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
